Oct 06 2023 This Week in Cardiology
Medscape,
Please note that the text below is not a full transcript and has not been copyedited.
Please note that the text below is not a full transcript and has not been copyedited.
LIGNE SUPÉRIEURE : Enrobé entérique aspirine n’est pas significativement moins efficace que l’aspirine non enrobée pour prévenir…
TOPLINE: Enteric-coated aspirin is not significantly less effective than uncoated aspirin is in preventing death, myocardial…
1. There was no significant difference in all-cause mortality and need for invasive mechanical ventilation among patients…
This transcript has been edited for clarity. Robert A. Harrington, MD: Hi. This is Bob Harrington from Stanford University.
1. Risk of cardiovascular death, myocardial infarction, stroke, and revascularization was lower in the fixed-dose combination…
Results of a new pragmatic trial called ADAPTABLE will give clinicians and their patients with heart disease more to discuss…
July 15, 2021 11 min read Source/Disclosures Published by: Source: Jones WS, et al.
Aspiriini ja muut asetyylisalisyylihappoa sisältävät lääkkeet ehkäisevät sydänpotilaiden uusia oireita ja sairastumisia, mutta…
心血管疾病是一个全民关注的健康话题。根据2020年国家心血管病中心发布的《中国心血管病健康和疾病报告2019》数据显示,中国心血管病现患人数3.30亿,心血管病死亡占城乡居民总死亡原因的首位,可以说是“谈之色变”的疾病 。如今,我国心血管病负担日渐加重,已成…
-- A new study found no difference in the rate of heart attack, stroke, or death between low- or high- dose aspirin in people…
8 名の先生が役に立ったと考えています。 米・Duke UniversityのW. Schuyler Jones氏らは、動脈硬化性心血管疾患(ASCVD)患者1万5,000例超を対象に、アスピリンの低用量(81mg/日)投与と高用量(325mg/日)投与の有…
This transcript has been edited for clarity. Michelle L. O'Donoghue, MD, MPH: Hi.
Please note that the text below is not a full transcript and has not been copyedited.
/dpa Durham/North Carolina Eine neuartige pragmatische Studie zeigt, dass US-Patienten die von den rzten in der sekundren…
© Shutterstock / fizkes Kobieta trzymająca na dłoni tabletkę Aspiryna lub inaczej kwas acetylosalicylowy (ASA) jest jednym z…
(HealthDay News) — For patients with established atherosclerotic cardiovascular disease, there is no significant difference in…
A large landmark study found that low-dose and regular-strength aspirin is equally safe and effective for preventing additional…
HealthDay News — For patients with established atherosclerotic cardiovascular disease, there is no significant difference in…
Patients assigned to 325-mg aspirin had higher incidence of dose switching, fewer median days of exposure to assigned dose…
Um estudo publicado no último sábado (15/5) no periódico científico New England Journal of Medicine, revela que o uso de…
This transcript has been edited for clarity. Michelle L. O'Donoghue, MD, MPH: Hi.
-- For patients with established atherosclerotic cardiovascular disease, there is no significant difference in cardiovascular…
(HealthDay News) -- For patients with established atherosclerotic cardiovascular disease, there is no significant difference in…
This Aug. 23, 2018 file photo shows an arrangement of aspirin pills in New York.
No significant difference in cardiovascular events or major bleeding was shown between patients with established coronary heart…
Meeting Coverage > ACC But landmark trial was hampered by crossover An 81-mg dose of daily aspirin isn't less effective than…
May 15, 2021 — The ADAPTABLE trial found no significant differences in cardiovascular events or major bleeding in patients with…
There was no significant difference in cardiovascular events or major bleeding between patients with established coronary heart…
Study also finds similar rates of major bleeding with 81 and 325 mg daily doses, though adherence is strikingly better among…
Studyalsofindssimilarrates of major bleeding with 81 and 325 mgdailydoses, though adherence is strikingly better among those…